德克薩斯州 的 過重 臨床試驗
54 項針對 過重 的研究正在 德克薩斯州 各地點尋找參與者。
德克薩斯州 的城市
- San Antonio33 項研究
- Houston33 項研究
- Dallas20 項研究
- Austin18 項研究
- Grand Prairie11 項研究
- Sugar Land10 項研究
- The Woodlands10 項研究
- Pharr10 項研究
- El Paso8 項研究
- Amarillo7 項研究
- Brownsville7 項研究
- Mesquite6 項研究
- Corpus Christi5 項研究
- Fort Worth4 項研究
- Lubbock3 項研究
- Wichita Falls3 項研究
- Garland3 項研究
- Tyler3 項研究
官方研究文本（英文）
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- DM Clinical, Houston
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- 還有 3 項
招募中3 期
8 至 18 歲 · 所有性別 · 更新於 2026年9月30日 · NCT07253285AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- UT Southwestern Med Center, Dallas
- PlanIt Research, PLLC, Houston
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07533175Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Amarillo Medical Specialists /ID# 282380, Amarillo
- Elligo Clinical Research Center /ID# 282166, Austin
- Velocity Clinical Research - Dallas /ID# 282734, Dallas
- 還有 2 項
招募中2 期
18 至 75 歲 · 所有性別 · 更新於 2026年9月29日 · NCT07752979AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Amarillo Medical Specialists, Amarillo
- North Texas Endocrine Center, Dallas
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07720271A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07595549A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Amarillo Med Spec LLP, Amarillo
- Texas Diabetes & Endocrinology, Austin
- Pinnacle Clinical Research, Brownsville
- 還有 7 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- 還有 10 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07794579Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Endeavor Clinical Trials, San Antonio
招募中1 期
18 至 65 歲 · 所有性別 · 更新於 2026年9月28日 · NCT07399678A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Dell Children's Medical Center - PIN, Austin
- Driscoll Children's Hospital, Corpus Christi
- McGovern Medical School, Houston
- 還有 4 項
招募中3 期
6 至 17 歲 · 所有性別 · 更新於 2026年9月24日 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
招募中3 期
18 至 70 歲 · 所有性別 · 更新於 2026年9月24日 · NCT06937086Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
招募中3 期
18 至 70 歲 · 所有性別 · 更新於 2026年9月24日 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07282600Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
- 還有 22 項
招募中3 期
45 至 99 歲 · 所有性別 · 更新於 2026年9月22日 · NCT07037433Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- JCCT - Juno Bellaire Site, Bellaire
- Epic Medical Research - DeSoto, DeSoto
- Valley Institute of Research - Fort Worth, Fort Worth
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- The University of Texas Health Science Center at Houston, Bellaire
- Velocity Clinical Research, Dallas, Dallas
- UT Southwestern Medical Center, Dallas
- 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07321886A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07784270A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- FutureSearch Trials of Dallas, Dallas
- PlanIt Research, PLLC, Houston
- 還有 2 項
招募中2 期
18 至 75 歲 · 所有性別 · 更新於 2026年9月22日 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- UT Southwestern Medical Center, Dallas
- Juno Research, Houston
- Activian Clinical Research, Kingwood
- 還有 7 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- FutureSearch Trials of Neurology, Austin
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07369011Semaglutide for Post-Smoking Cessation Weight Management
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston, Houston
招募中2 期歡迎健康志工
18 至 75 歲 · 所有性別 · 更新於 2026年9月21日 · NCT06173778A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Austin
- AURORA-2 Clinical Site, Brownsville
- AURORA-2 Clinical Site, DeSoto
- 還有 10 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月16日 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Austin
- AURORA-1 Clinical Site, Brownsville
- AURORA-1 Clinical Site, DeSoto
- 還有 8 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月16日 · NCT07743463A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Bellaire Clinical Research, LLC, Bellaire
- South Texas Research Institute - Brownsville, Brownsville
- South Texas Clinical Research, Corpus Christi
- 還有 8 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT07351045A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- 還有 2 項
招募中2 期
18 至 75 歲 · 所有性別 · 更新於 2026年9月14日 · NCT06897475A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Austin
- ACCOMPLISH-2 Research Site, Farmers Branch
- ACCOMPLISH-2 Research Site, Houston
- 還有 4 項
招募中3 期歡迎健康志工
18 至 79 歲 · 所有性別 · 更新於 2026年9月11日 · NCT07654374AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Epic Medical Research, DeSoto
- Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
- Biorhythms Center for Integrative Sleep Medicine, El Paso
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月11日 · NCT07571005AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Epic Medical Research, DeSoto
- Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
- Biorhythms Center for Integrative Sleep Medicine, El Paso
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月9日 · NCT07571109Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Cedar Health Research, Dallas
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月9日 · NCT07770841A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
- Biopharma Informatic, LLC, Houston
- 還有 5 項
招募中2 期
18 至 75 歲 · 所有性別 · 更新於 2026年9月8日 · NCT07215559A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
- 還有 3 項
招募中2 期
18 至 75 歲 · 所有性別 · 更新於 2026年9月8日 · NCT06143956A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- ICON, San Antonio
招募中1 期歡迎健康志工
18 至 55 歲 · 所有性別 · 更新於 2026年9月4日 · NCT07767175A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- 還有 3 項
招募中4 期
18 歲及以上 · 所有性別 · 更新於 2026年9月4日 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Amarillo
- Kailera Clinical Site, Brownsville
- Kailera Clinical Site, DeSoto
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月3日 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Amarillo
- Kailera Clinical Site, Bellaire
- Kailera Clinical Site, DeSoto
- 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月3日 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Cedar Health Research, LLC, Dallas
- 還有 9 項
招募中3 期
18 至 99 歲 · 所有性別 · 更新於 2026年9月3日 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Osvaldo A Brusco MD PA, Corpus Christi
- 還有 2 項
招募中3 期
18 至 99 歲 · 所有性別 · 更新於 2026年9月3日 · NCT07684144A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- ICON Early Phase Services, LLC, San Antonio
招募中1 期歡迎健康志工
18 至 65 歲 · 所有性別 · 更新於 2026年9月1日 · NCT07654972Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Epic Medical Research - DeSoto, DeSoto
- South Texas Research Institute, Edinburg
- Biopharma Informatic, LLC, Houston
- 還有 5 項
招募中3 期
18 至 99 歲 · 所有性別 · 更新於 2026年8月27日 · NCT07575399資料來源：ClinicalTrials.gov，擷取日期 2026年10月1日。各研究自行設定資格標準；由研究團隊決定參與者資格。